265 related articles for article (PubMed ID: 18471515)
1. Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.
Klade CS; Wedemeyer H; Berg T; Hinrichsen H; Cholewinska G; Zeuzem S; Blum H; Buschle M; Jelovcan S; Buerger V; Tauber E; Frisch J; Manns MP
Gastroenterology; 2008 May; 134(5):1385-95. PubMed ID: 18471515
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects.
Firbas C; Jilma B; Tauber E; Buerger V; Jelovcan S; Lingnau K; Buschle M; Frisch J; Klade CS
Vaccine; 2006 May; 24(20):4343-53. PubMed ID: 16581161
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C.
Wedemeyer H; Schuller E; Schlaphoff V; Stauber RE; Wiegand J; Schiefke I; Firbas C; Jilma B; Thursz M; Zeuzem S; Hofmann WP; Hinrichsen H; Tauber E; Manns MP; Klade CS
Vaccine; 2009 Aug; 27(37):5142-51. PubMed ID: 19559112
[TBL] [Abstract][Full Text] [Related]
4. Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.
Schlaphoff V; Klade CS; Jilma B; Jelovcan SB; Cornberg M; Tauber E; Manns MP; Wedemeyer H;
Vaccine; 2007 Sep; 25(37-38):6793-806. PubMed ID: 17686555
[TBL] [Abstract][Full Text] [Related]
5. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
[TBL] [Abstract][Full Text] [Related]
6. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
7. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
8. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
[TBL] [Abstract][Full Text] [Related]
9. HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.
Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
Vaccine; 2006 Jun; 24(26):5491-7. PubMed ID: 16725235
[TBL] [Abstract][Full Text] [Related]
10. Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination.
Castellanos M; Cinza Z; Dorta Z; Veliz G; Vega H; Lorenzo I; Ojeda S; Dueñas-Carrera S; Alvarez-Lajonchere L; Martínez G; Ferrer E; Limonta M; Linares M; Ruiz O; Acevedo B; Torres D; Márquez G; Herrera L; Arús E
J Gene Med; 2010 Jan; 12(1):107-16. PubMed ID: 19866482
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy.
Yutani S; Yamada A; Yoshida K; Takao Y; Tamura M; Komatsu N; Ide T; Tanaka M; Sata M; Itoh K
Vaccine; 2007 Oct; 25(42):7429-35. PubMed ID: 17845828
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.
Spangenberg HC; Viazov S; Kersting N; Neumann-Haefelin C; McKinney D; Roggendorf M; von Weizsäcker F; Blum HE; Thimme R
Hepatology; 2005 Oct; 42(4):828-37. PubMed ID: 16175596
[TBL] [Abstract][Full Text] [Related]
13. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.
Schirren CA; Jung MC; Gerlach JT; Worzfeld T; Baretton G; Mamin M; Hubert Gruener N; Houghton M; Pape GR
Hepatology; 2000 Sep; 32(3):597-603. PubMed ID: 10960455
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine.
Firbas C; Boehm T; Buerger V; Schuller E; Sabarth N; Jilma B; Klade CS
Vaccine; 2010 Mar; 28(12):2397-407. PubMed ID: 20060945
[TBL] [Abstract][Full Text] [Related]
15. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
[TBL] [Abstract][Full Text] [Related]
16. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
Heeg MH; Ulsenheimer A; Grüner NH; Zachoval R; Jung MC; Gerlach JT; Raziorrouh B; Schraut W; Horster S; Kauke T; Spannagl M; Diepolder HM
Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
Semmo N; Krashias G; Willberg C; Klenerman P
J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
[TBL] [Abstract][Full Text] [Related]
18. Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection.
Jeong HY; Lee YJ; Seo SK; Lee SW; Park SJ; Lee JN; Sohn HS; Yao S; Chen L; Choi I
J Leukoc Biol; 2008 Mar; 83(3):755-64. PubMed ID: 18086898
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.
Penna A; Missale G; Lamonaca V; Pilli M; Mori C; Zanelli P; Cavalli A; Elia G; Ferrari C
Hepatology; 2002 May; 35(5):1225-36. PubMed ID: 11981773
[TBL] [Abstract][Full Text] [Related]
20. Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C.
Ulsenheimer A; Gerlach JT; Gruener NH; Jung MC; Schirren CA; Schraut W; Zachoval R; Pape GR; Diepolder HM
Hepatology; 2003 May; 37(5):1189-98. PubMed ID: 12717401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
